Company profile: NewLimit
1.1 - Company Overview
Company description
- Provider of epigenetic reprogramming medicines and technologies to extend human healthspan by restoring youthful function in aging cells and targeting age-related diseases. Offerings include single-cell genomics, machine learning models for experimental prioritization, in silico experimental models, epigenetic editing, and functional genomics screens.
Products and services
- Epigenetic Editing: Precision-engineered techniques that modify the epigenome to change a cell’s function or type, reversing aging signatures to rejuvenate cells
- Epigenetic Reprogramming Medicines: Therapeutic-grade medicines that alter the epigenome to restore youthful cellular function, engineered to treat age-related diseases by reprogramming aging cells
- Single Cell Genomics: Research-grade technologies analyzing genetic material at single-cell level to understand cellular function and aging, generating per-cell data for age-related profiling
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to NewLimit
Curio Bioscience
HQ: United States
Website
- Description: Provider of spatial transcriptomics tools for cancer biology, developmental biology, immunology, and neuroscience: Curio Seeker kits for whole transcriptome mapping of fresh-frozen tissues, compatible with eukaryotes and fitting sequencing workflows without specialized equipment; Curio Trekker for single-cell spatial mapping without deconvolution or segmentation; and the Seeker bioinformatics pipeline to process FASTQ into spatial maps.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Curio Bioscience company profile →
Qualtrax
HQ: United States
Website
- Description: Provider of intranet-based quality and document control solutions supporting regulatory requirements in regulated industries. Offerings include Ideagen Quality Management for document control, workflow automation, and risk management, and specialized Food & Beverage editions focused on supplier management, risk assessment, and compliance with food safety standards. Based in Christiansburg, Virginia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Qualtrax company profile →
Geospiza
HQ: United States
Website
- Description: Provider of software systems for workflow management of genetic analysis, offering GeneSifter Analysis Edition, a cloud-based data analysis product for microarray and sequencing data, and GeneSifter Lab Edition, a software platform supporting laboratory workflows.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Geospiza company profile →
Triomics
HQ: United States
Website
- Description: Provider of an oncology-focused generative AI platform for clinical trial matching. Offers OncoLLM to process clinical and genomic data; Prism for EHR-integrated trial matching; Harmony for EHR data curation for tumor registries and precision oncology; Symphony to streamline care via triage, identifying missing data, and pre-charting; and Clinical Navigators for clinical workflow integration, trial navigation, and registry engagement.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Triomics company profile →
Tahoe Bio
HQ: United States
Website
- Description: Provider of AI-powered tools that simulate human cell responses to guide drug discovery, including Mosaic for generating large-scale single-cell datasets and high-resolution in vivo phenotypic and transcriptomic profiling, single-cell RNA pooling to analyze drug action across diverse patients, and in vivo drug-cell interaction studies; initial applications in oncology; open-sources the Tahoe-100M dataset.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tahoe Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for NewLimit
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to NewLimit
2.2 - Growth funds investing in similar companies to NewLimit
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for NewLimit
4.2 - Public trading comparable groups for NewLimit
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →